ARTICLE |
Correspondence to: Miranda D. Grounds, Dept. of Anatomy & Human Biology, The University of Western Australia, Nedlands, Western Australia 6907. E-mail: mgrounds@anhb.uwa.edu.au
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The role of tumor necrosis factor-alpha (TNF-), an important mediator of the inflammatory response after injury, was investigated in regenerating skeletal muscle. The pattern of expression of TNF-
during muscle regeneration was examined by immunohistochemistry in tissue sections of crush-injured or transplanted muscle autografts and in primary cultures of adult skeletal muscle. TNF-
was highly expressed in injured myofibers, inflammatory cells, endothelial cells, fibroblasts, and mast cells. Myoblasts and myotubes also expressed TNF-
in primary muscle cultures and tissue sections. The essential role of TNF-
and its homologue lymphotoxin-alpha (LT-
) during muscle regeneration was assessed by basic histology in TNF-
(-/-) and TNF-
(-/-)/LT-
(-/-) mice. No difference was apparent in the onset or pattern of muscle regeneration (i.e., inflammatory response, activation and fusion of myoblasts) between the two strains of null mice or between nulls and normal control mice. However, both strains of null mice appeared more prone to bystander damage of host muscle and regeneration distant from the site of injury/transplantation. Although expression of TNF-
may play an important role in muscle regeneration, the studies in the null mice show that redundancy within the cytokine system (or some other response) can effectively compensate for the absence of TNF-
in vivo.
(J Histochem Cytochem 49:9891001, 2001)
Key Words:
tumor necrosis factor-, lymphotoxin-
, muscle regeneration, immunohistochemistry, null mice, cytokine, histology
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
MUSCLE REPAIR is a complex process, and it is of considerable interest to understand what factors are critical for successful muscle regeneration (), which is produced by the majority of activated leukocytes (
plays several important roles in inflammation, including activation and chemotaxis of leukocytes, expression of adhesion molecules on neutrophils and endothelial cells, and regulation of the secretion of other proinflammatory cytokines (
is part of a complex network of cytokines and is capable of initiating cytokine cascades involving both synergistic and inhibitory reactions, which control the synthesis and expression of other cytokines, hormones, and their receptors (
induces the expression of interleukin-1 (IL-1) and interferon-gamma (IFN-
), and these cytokines are of particular interest in muscle regeneration because of their ability to induce inflammation (
The cytokine lymphotoxin-alpha (LT-) was also examined in this study because of its structural homology to TNF-
and its ability to bind the TNF receptors (TNF-Rs) (see Fig 1A). LT-
has similar proinflammatory effects to TNF-
but exerts only a partial agonistic effect (
is of primarily B- and T-lymphocyte origin, and can exist in a soluble homotrimeric form or in membrane-bound heterotrimeric form in complex with lymphotoxin-beta (LT-ß) (
|
Increased expression of TNF- was observed in muscle fibers biopsied from patients with Duchenne's muscular dystrophy (DMD) (
enhanced myoblast proliferation and inhibited differentiation and fusion of mouse C2 cells (
inhibited both proliferation and fusion of rat L8 myoblasts (
induces muscle proteolysis and is involved in (cachexia) muscle wasting (
has also been implicated in a number of non-muscle inflammatory diseases, including rheumatoid arthritis (
and the inflammatory response are also regulated by glucocorticoids (
before partial hepatectomy has been shown to inhibit liver regeneration in rats (
have also been used clinically (
's role in inflammation and regeneration. These combined observations demonstrate the crucial role of TNF-
in processes such as tissue repair and strongly suggest that TNF-
may play a critical role in normal skeletal muscle necrosis and regeneration.
This study describes the pattern of TNF- expression in uninjured and regenerating skeletal muscle in three mouse strains, C57BL/10ScSn (the parental strain for mdx and the control strain for the knockout mice), SJL/J, and BALB/c, and in dystrophic mdx muscle. The SJL/J and BALB/c strains are compared because of the well-documented differences in their capacity for muscle regeneration (
(-/-) and TNF-
(-/-)/LT-
(-/-) mice. The results indicate that although TNF-
plays a role in muscle regeneration, there is no absolute requirement for it to be present.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animals
Animals were fed and housed according to guidelines of the National Health & Medical Research Council (NH&MRC) of Australia, and all procedures were approved by the Animal Experimentation Ethics Committee at the University of Western Australia. All mice, apart from the null strains, were obtained from the Animal Resource Centre (Murdoch University, Western Australia). C57/BL10ScSn mice (hereafter referred to as C57/BL) were used as controls for TNF- null and TNF-
/LT-
null mice. The TNF-
knockout (SloanKettering; New York, NY) (
/LT-
(HoffmanLaRoche; Basel, Switzerland) double-knockout mice were bred on a C57BL/129 background and were kindly donated by Hugh Reid (LaTrobe University; Victoria, Australia). Uninjured and experimentally injured adult C57/BL, SJL/J, BALB/c, TNF-
(-/-) null, and TNF-
(-/-)/LT-
(-/-) null mice were used for basic histology and immunohistochemistry. Uninjured dystrophic mdx mice were also used to model the endogenous muscle injury in DMD. Ten TNF-
(-/-) and 14 TNF-
(-/-)/LT-
(-/-) mice of a range of ages and sexes were used, as shown in Table 1. The relatively small number of these knockout mice was due to their very limited availability.
|
Surgical Procedures
All surgical procedures were carried out under halothane anesthesia and in strict accordance with NH&MRC guidelines. After surgery, mice were transferred to standard cages with food and water ad libitum and allowed to recover in a temperature- and light-sensitive environment.
Crush Injury.
Mice received a single severe transverse crush injury to the mid-region of the tibialis anterior (TA) muscle of both legs using a pair of artery forceps, as described previously (
Whole Muscle Graft.
Autografts of intact whole extensor digitorum longus (EDL) muscle were transplanted over the TA muscle as described in detail elsewhere (
Sham Injury.
Specimens of TA muscles from C57/BL mice that had undergone the surgical procedure, including incision and suturing of the skin but without muscle crush or graft, were used to check the host muscle for TNF- staining in response to the basic surgical procedure.
Denervation.
Muscles in the hindlimb of BALB/c mice were denervated by removal of a section of the sciatic nerve, as described by
Primary Cultures of Myoblasts
Muscle was taken from the hindlimbs and lower back region of 46-week-old C57/BL and TNF-(-/-)/LT-
(-/-) mice for primary culture, as previously described (
Tissues
Muscle samples were fixed in paraformaldehyde [4% (v/v) in PBS, pH 7.6] for 6 hr and processed for paraffin embedding. Sections of 5 µm were stained with hematoxylin and eosin (for histological analysis) or with antibodies to TNF- (for immunohistochemistry).
Immunohistochemistry
The TNF- staining protocol was modified from
antibody (1:400; Genzyme, Cambridge, MA) or PBS only (negative control) at 4C overnight. Sections were incubated for 30 min with biotinylated goat anti-rabbit IgG (1:200; Jackson Laboratories, West Chester, PA), followed by incubation with avidin Dperoxidase (1:100) for 30 min. Diaminobenzidine (DAB) color reagent [1:10 (v/v) in peroxide buffer; Pierce, Rockford, IL] was applied for 4 min. Sections were counterstained with Gill's hematoxylin. TNF-
protein stained brown (DAB) and cell nuclei stained blue (hematoxylin).
Normal mouse thymus was used as a positive control for TNF- staining (
(-/-) and TNF-
(-/-)/LT-
(-/-) muscle was stained with TNF-
antibody as a negative control for immunohistochemistry. TNF-
staining in paraformaldehyde-fixed cultured cells followed the same protocol minus quenching of endogenous peroxidases, and blocking time in FCS was reduced to 20 min. TNF-
(-/-)/LT-
(-/-) cultures were used as negative controls.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Uninjured, Dystrophic, and Denervated Muscle
The histological appearance of uninjured skeletal muscle from BALB/c, C57/BL, and SJL/J mice was similar. Furthermore, no differences were noted among muscles from these mice aged 3 weeks, 10 weeks, 1 and 3 years of age (data not shown). Dystrophic mdx muscle showed variation in muscle fiber size, many mature muscle fibers with centrally placed nuclei (characteristic of regenerated mouse muscle), focal areas of necrosis with infiltrating phagocytic cells, and areas of regeneration (not shown), as has been well described elsewhere (
Antibodies to TNF- showed little staining of uninjured muscle (not shown). No differences were visible in the staining among strains or among muscle at 3 weeks, 10 weeks, 1 and 3 years of age (not shown). TNF-
staining was not seen in mast cells of uninjured muscle, although mast cells were clearly present, as demonstrated by Toluidine blue staining (
staining was increased in regions of necrosis and inflammation (see Fig 2), and strong TNF-
staining was seen in mast cell granules in mdx muscles (similar to staining in Fig 2F).
|
At 1 week after denervation, TNF- staining was similar to uninjured muscle, but at 4 weeks there was increased TNF-
staining in atrophic muscle fibers and in muscle spindles (muscle spindle staining as in Fig 2H). Muscle spindles were not stained in uninjured muscle (not shown). TNF-
staining in mast cells did not change as a result of denervation.
Muscle Regeneration After Experimental Injury for Control Strains (C57/BL, SJL/J, and BALB/c)
Crush Injury.
The overall histological events of regeneration after crush injury were similar in all strains. In accordance with the literature (
Whole Muscle Graft.
Very small differences in the timing of regeneration (i.e., onset of inflammation and myotube formation) were seen between whole muscle autografts in BALB/c and SJL/J mice, as has been described previously (
TNF- Staining of Muscles Regenerating After Crush Injury or Grafting
No differences were observed between the intensity of staining with TNF- antibodies in regenerating muscles (crushed or grafted) of BALB/c, C57/BL, and SJL/J mice. Necrotic myofibers stained strongly TNF-
-positive and the sarcoplasm of the uninjured portion of crush-injured muscle also stained TNF-
-positive (Fig 2B). Sections of single- and double-knockout muscle stained with TNF-
antibody (as a negative control) showed some staining of damaged myofibers but no staining of inflammatory cells (Fig 2C), demonstrating that although some nonspecific binding occurs, the increased TNF-
staining seen in injured TNF-
(+/+) muscles is real. The host TA muscle underlying the EDL autografts also showed strong TNF-
staining across all time points examined (Fig 2D). However, sham-operated TA muscle was TNF-
-negative, indicating that the presence of the graft is necessary to increase TNF-
expression in the host muscle (not shown).
TNF- antibodies stained all neutrophils in crush-injured muscle at Day 1 (Fig 2E, inset), and the staining intensity and number of positive neutrophils decreased after this time. Macrophages in crush-injured and grafted muscles stained strongly for TNF-
(Fig 2E). The small numbers of lymphocytes present in injured muscle and endothelial cells in small blood vessels were also TNF-
-positive.
Lymphocytes were identified as cells with a small rim of cytoplasm surrounding a dense, non-lobulated nucleus. Mast cells in injured muscle were strongly TNF--positive, with staining localized to mast cell granules (Fig 2F). TNF-
-positive muscle spindles were present in crush-injured muscles and, after muscle transplantation, in both the EDL graft and host TA muscle (Fig 2H). Both the inner and outer spindle capsule membranes stained TNF-
-positive [see
-positive.
Myoblasts were difficult to identify in sections of crush-injured muscle. Crescent-shaped cells, presumed to be myoblasts (activated satellite cells), were seen within the contour of the basement membrane of necrotic myofibers in grafts. These "cuffing" myoblasts were TNF--negative to moderately TNF-
-positive. Myotubes in crush-injured and grafted muscles ranged from TNF-
-negative to moderately TNF-
-positive, and the latter were usually larger more mature myotubes. In general, TNF-
staining was confined to the cytoplasm of myotubes (Fig 2G). The regenerated zone of the muscle usually had a much lower intensity of TNF-
staining than freshly injured and necrotic muscle.
Tissue Culture Studies
To specifically address the production of TNF- in myoblasts and myotubes, immunostaining was also carried out on primary cultures of skeletal muscle. Muscle cultures from BALB/c, C57/BL, and SJL/J mice showed intense cytoplasmic staining with TNF-
antibodies in mononucleated cells and myotubes, often present in mononuclear cells in a granular distribution (Fig 3C and Fig 3D). Negative controls, in which the primary antibody was omitted, showed some scattered nonspecific staining (Fig 3A). In addition, muscle cultures from TNF-
(-/-)/LT-
(-/-) double-knockout mice served as negative controls. The presence of some TNF-
staining in adherent mononuclear cells confirmed some nonspecific staining in myoblasts (Fig 3B).
|
Regeneration in Single [TNF-(-/-)]- and Double [TNF-
(-/-)/LT-
(-/-)]-Knockout Mice
It was noted that surgery was difficult on the TNF- single- and double-knockout mice because of their thin, weak skin, soft muscle, and unexpectedly high number of capillaries in the muscle. The soft muscle and connective tissue of the knockout mice was also noted during the preparation of cultures from double-knockout mice. The single-knockout (and to a lesser extent the double-knockout) mice were hyperactive and appeared highly stressed, as emphasized by their prominent hair loss. Possible reasons for these observations are outlined in the Discussion.
The pattern of muscle regeneration after crush injury (12 muscles sampled per strain) or in whole muscle grafts (eight muscles sampled per strain) in both single [TNF-(-/-)- and double (TNF-
(-/-)/LT-
(-/-)]-knockout mice appeared histologically normal at all times. Detailed examination revealed no apparent differences in the timing or extent of inflammation or new muscle formation between (a) single- and double-knockout muscle or (b) C57/BL control and single- or double-knockout muscle (data not shown).
Of particular interest was the observation that in single- and double-knockout mice, transverse sections through host TA muscle underlying whole muscle autografts regularly contained newly formed, centrally located myotubes (Fig 4E). Such foci of necrosis/regeneration were not present in host quadriceps or gastrocnemius muscle, i.e., muscles distant from the grafted site, or in host TA muscles taken at Day 1 after muscle autografting (data not shown). It was also noted that inflammatory cell infiltration in the host of the knockout mice was conspicuous between myofibers (Fig 4F) compared with normal control host muscle. Inflammatory cells were particularly conspicuous between muscle fascicles. Such damage and subsequent regeneration (i.e., myotube formation) was never seen deep in the host muscles of control C57BL (nor in BALB/c or SJL/J) mice in response to the presence of overlying whole muscle grafts.
|
Antibodies to TNF- showed some very low nonspecific staining over injured and uninjured myofibers in both strains of null mice (negative controls). However, no TNF-
staining was seen in inflammatory cells or mast cells of these null mice, emphasizing the good specificity of the TNF-
antibody (Fig 2C).
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Although immunostaining showed strong upregulation of TNF- in many cells in response to skeletal muscle damage, the absence of TNF-
and its homologue LT-
had no apparent effect on the processes of regeneration and new muscle formation in TNF-
(-/-) and TNF-
(-/-)/LT-
(-/-) mice. An important finding was a high incidence of "bystander" damage to adjacent host muscles in response to overlying muscle grafts in the single- and double-knockout host mice. These observations are discussed in detail below.
Immunostaining of Normal and Regenerating Muscle
The lack of TNF- expression in normal uninjured skeletal muscle indicates that, unlike in other tissues (
is not involved in muscle homeostasis and is expressed only in situations of injury and inflammation. The absence of TNF-
staining in uninjured skeletal muscle is highlighted by the lack of TNF-
staining of host muscles in sham-operated mice, indicating that significant muscle disturbance or the presence of necrotic muscle in the overlying graft is required for detectable TNF-
expression in skeletal muscle.
After experimental injury, myofibers in both the directly injured and "uninjured" regions of muscle expressed TNF-. This was seen in muscle adjacent to the crush injury and also in the "uninjured" host TA muscle underlying muscle grafts. Expression of TNF-
by damaged myofibers after acute injury has not been described previously. This observation is compatible with results showing TNF-
staining in dystrophic mdx myofibers and in muscle fibers of DMD patients (
, supporting the reported role of TNF-
in the induction of muscle proteolysis (
was also seen in the present study in atrophic muscle fibers at 4 weeks after denervation. That staining of myotubes in vivo was due to endogenous production of TNF-
rather than to exogenous TNF-
protein binding to the cell surface is supported by the strong TNF-
staining of myotubes in tissue culture.
TNF- staining of infiltrating inflammatory cells in injured muscle confirmed reports of TNF-
production by activated leukocytes (
(
staining observed in these cells. Neutrophils are also known to produce TNF-
(
-positive. The decrease in the proportion of TNF-
-positive neutrophils across the time points in crush-injured muscle indicates that peak neutrophil activation occurs at Day 1 and subsequently decreases, in agreement with other studies in regenerating muscle (
. The accuracy of TNF-
staining in this study was further reinforced by the strong positive TNF-
staining seen in mast cell granules. It is well documented that TNF-
is stored within cytoplasmic granules (
(
in the muscle injury models described here.
Pathways of inflammatory cell recruitment, activation, and cell death differ among different types of muscle injury ( staining observed in mdx muscle and in experimentally injured muscle. The relatively low TNF-
staining intensity observed in all cells except mast cells in mdx muscle indicates that the inflammatory cell activation and migration of specific subsets of cells (
production.
Muscle Spindles
TNF- staining was observed in muscle spindles in cross-sections of injured and denervated muscle but was not seen in normal uninjured muscle. Muscle spindles are mechanoreceptors specialized to monitor changes in muscle length (
. Staining of intrafusal myofibers of muscle spindles indicates that a response of both extrafusal (i.e., "normal") and intrafusal (i.e., spindle) muscle fibers to injury is the production of TNF-
. The presence of TNF-
in the capsule cells of muscle spindles suggests that TNF-
may also play a role in regeneration of the associated neuromuscular junctions (
Regeneration in TNF- Knockout Mice
The first part of this study showed that TNF- is highly expressed in injured and regenerating skeletal muscle. However, the absence of TNF-
had no effect on the timing and extent of inflammation and new muscle formation in regenerating skeletal muscles of null mice. No reduced macrophage activity was apparent in the TNF-
(-/-) mice, in agreement with results by
(in null mice) has no effect on liver regeneration, based on assessment of both cell proliferation and liver weights (Marino, personal communication). These observations contrast with impaired liver regeneration reported in situations in which TNF-
is still present but its activity is blocked by antibodies (
(TNF-RI and/or TNF-RII) (
protein (in both of these situations) presumably does not stimulate compensatory upregulation of other cytokines or host cellular responses (
protein as in the present study. Our in vivo studies in single- and double-knockout mice strongly indicate that any role played by TNF-
in skeletal muscle regeneration can be performed efficiently and effectively by the upregulation of other cytokines (when TNF-
is not present).
The important distinction between the markedly different outcomes (seen in both skeletal muscle and liver) when TNF- is present but its activity is blocked either by antibodies to TNF-
itself or by blocked or absent receptors, compared with situations in which TNF-
protein is absent (and the probable consequence of an altered host cytokine response), has critical implications for the design of therapeutic strategies to modulate cytokine levels.
Cytokine Interactions
TNF- exists within a complex network of interactions with a multitude of other cytokines. In TNF-
null mice, interleukin-12 (IL-12) expression is greatly increased (
are co-stimulators for IFN-
, one of the essential cytokines for regulation of the inflammatory response (
, could act in a compensatory manner to induce and maintain appropriate IFN-
levels. IFN-
induces macrophage activation, an important event in muscle regeneration (
, is a primary mediator of the inflammatory response (
. IL-1 is also likely to be important in muscle regeneration because of its roles in angiogenesis, fibroblast proliferation, and chemotaxis (
, its direct effects on proliferation and fusion of myoblasts (
IL-6 expression increases in regenerating and diseased skeletal muscle (. Another cytokine that may be of importance in muscle regeneration in the absence of TNF-
is transforming growth factor-beta (TGF-ß) (
, LT-
, and IL-1 (
, TGF-ß is also elevated in skeletal muscle disorders (
The cytokines TNF-, IL-1, IL-6, and IFN-
can stimulate the production of glucocorticoid hormones by the pituitary and, in turn, glucocorticoids inhibit the production of these cytokines and thus exert an immunomodulatory effect (for review see
Oligomerization of receptors for TNF- has been reported to occur in the absence of ligand binding (
(or LT-
or LT-
2ß1) without the specific ligandreceptor interaction. It is not known to what extent this might occur during injury. Such potential receptor signaling in the absence of TNF-
or LT-
ligand binding in the knockout mice must therefore also be considered as a possible contributing factor to the normal regeneration seen in null mice.
Studies in double-knockout mice indicate that, like TNF-, LT-
has no essential role in muscle regeneration, and therefore LT-
1ß2 and LT-
2ß1 also have nonessential roles in the process. The similarity between regeneration in the single- and double-knockout mice indicates either that the cytokines upregulated in the absence of TNF-
are also sufficient to compensate for the lack of LT-
or that a different cytokine expression profile exists in the single-knockout mice that has essentially the same overall function.
Observations of thin, weak skin, and soft muscle with many capillaries in the TNF- single- and double-knockout mice can be accounted for by the roles that TNF-
and other cytokines play in skin, angiogenesis and connective tissue. For example, keratinocyte proliferation is decreased and differentiation increased by TNF-
(
induces expression of cell adhesion molecules, such as ICAM on the surface of keratinocytes (
knockout mice could be due to deregulation of keratinocyte proliferation, differentiation, and adhesion. TNF-
also stimulates fibroblast proliferation in culture (
might result in decreased fibroblast proliferation and thus reduced connective tissue density. Because matrix metalloproteinases (MMPs) are involved in matrix remodeling during wound healing, angiogenesis, and tumor metastasis (for review see
(
Stress, Glucocorticoids, and TNF-
The hyperactive behavior and highly stressed appearance of the single-knockout mice may be accounted for by the complex cytokine interactions in vivo, and the strong interaction of TNF- with pituitary secretion of glucocorticoid hormones and the negative feedback interaction existing between them (as previously discussed). Upregulation of IL-1 may further exacerbate this situation because IL-1 is an important player in a number of the physical manifestations of stress (
"Bystander Effect" Damage to the Muscle of Knockout Mice
The unexpected presence of myotubes throughout the host muscle after graft implantation is not a feature of normal muscle. Although small areas of myotube formation are sometimes seen on the adjacent host muscle, this is characteristically restricted to the surface of the host TA muscle lying immediately beneath the graft and is considered to be the result of direct physical damage from the surgery. The presence of myotubes throughout the majority of host muscle sections beneath the graft in both single- and double-knockout mice, and their absence from both local and distant muscle at Day 1, strongly supports the idea that such myotubes are not normally present in TNF- null mice but are a consequence of the presence of the overlying graft. Bystander host muscle damage has also been observed in mouse soleus muscles after implantation of MHC-matched myoblasts (
.
The conspicuous number of leukocytes seen between host myofibers in knockout mice suggests that potential alterations in the absolute numbers or subtypes of inflammatory cells present in the double-knockout muscle could result from loss of the normal Type 1 inflammatory response with an increased or abnormal Type 2 inflammatory response ( revealed a complicated picture, with increased pathology of diaphragm muscle at 4 weeks of age but no effect on diaphragm muscle and decreased pathology of quadriceps muscles at 8 weeks in TNF-
(-/-)/mdx mice (
would ameliorate the dystrophic process, this was not supported by the complex results. The compensatory role of other cytokines in the absence of TNF-
probably accounted for this. In addition, there may be a sustained bystander effect in the TNF-
(-/-)/mdx mice. We propose that the alternative strategy of administering antibodies to block normal TNF-
activity (
![]() |
Footnotes |
---|
1 Present address: Division of Clinical Sciences, TVW Telethon Institute for Child Health Research, Subiaco, Western Australia.
![]() |
Acknowledgments |
---|
Supported by funding from the National Health and Medical Research Council of Australia.
We are grateful to Hugh Reid (LaTrobe University, Victoria) for the generous donation of single- and double-knockout mice, to Jim Hopley for technical assistance, to Marilyn Davies for expert surgery, and to Gayle Smythe, Jason White, and Stuart Hodgetts for advice and helpful discussions. Thanks also to Nguyen Ly of the Image Analysis and Acquisition Facility, UWA, for assistance with micrographs.
Received for publication December 18, 2000; accepted March 14, 2001.
![]() |
Literature Cited |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Ackerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM (1992) Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 263(4 pt 1):G579-585
Anderson JE, Vargas C, Weber M (2000) Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy. Cell Transplant 9:551-564[Medline]
Androlewicz MJ, Browning JL, Ware CF (1992) Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem 267:2542-2547
Argiles JM, GarciaMartinez C, Llovera M, LopezSoriano FJ (1998) The role of tumor necrosis factor- in muscle wasting disorders. Bas Appl Myol 8:371-380
Austin L, Burgess AW (1991) Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines. J Neurol Sci 101:193-197[Medline]
Barker D, Banks RW (1986) Muscle spindles. In Engel AG, Banker BQ, eds. Myology, Basic and Clinical. New York, McGrawHill, 309-341
Barker D, Hunt CC, McIntyre AK (1974) Muscle Receptors. Berlin, Springer-Verlag
Beutler B, Cerami A (1988) Tumor necrosis, cachexia, shock and inflammation: a common mediator. Annu Rev Biochem 57:505-518[Medline]
Bird DO (1978) The effect and response of a crushed lesion applied to a muscle spindle. Department of Anatomy & Human Biology, Perth, University of Western Australia
Brattsand R, Linden M (1996) Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 10(suppl 2):81-92[Medline]
Cannon JG, St Pierre BA (1998) Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem 179:159-167[Medline]
Cassatella MA (1995) The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21-26[Medline]
Copray JC, Brouwer N (1994) Selective expression of neurotrophin-3 messenger RNA in muscle spindles of the rat. Neuroscience 63:1125-1135[Medline]
Cullen MJ (1997) Dystrophin gene, protein and cell biology. In Browne SC, Lucy JA, eds. Muscle Regeneration. Cambridge, Cambridge University Press, 233-273
De Bleecker JL, Meire VI, Declercq W, Van Aken EH (1999) Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromusc Disord 9:239-246[Medline]
Decoster E, Cornelis S, Vanhaesebroeck B, Fiers W (1998) Autocrine tumor necrosis factor (TNF) and lymphotoxin (LT) alpha differentially modulate cellular sensitivity to TNF/LT-alpha cytotoxicity in L929 cells. J Cell Biol 143:2057-2065
De Maeyer E, De MaeyerGuignard J (1998) Interferons. In Thomson AW, ed. The Cytokine Handbook. San Diego, Academic Press, 491-516
Derynck R, Choy L (1998) Transforming growth factor-ß and its receptors. In Thomson AW, ed. The Cytokine Handbook. San Diego, Academic Press, 593-636
Douni E, Akassoglou K, Alexopoulou L, Georgopoulos S, Haralambous S, Hill S, Kassiotis G, Kontoyiannis D, Pasparakis M, Plows D (1996) Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm 47:27-38
Durbin JE, FernandezSesma A, Lee C, Rao TD, Frey AB, Moran TM, Vukmanovic S, GarciaSastre A, Levy DE (2000) Type I IFN modulates innate and specific antiviral immunity. J Immunol 164:4220-4228
Engelmann H, Holtmann H, Brakebusch C, Avni YS, Sarov I, Nophar Y, Hadas E, Leitner O, Wallach D (1990) Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 265:14497-14504
Fiers W (1991) Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199-212[Medline]
Forget MA, Desrosiers RR, Beliveau R (1999) Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can J Physiol Pharmacol 77:465-480[Medline]
Giror BP, Johnson JH, Brown T, Allen GL, Beutler B (1992) The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90:693-698[Medline]
Goebels N, DeRossi M, Hohlfeld R (1998) The role of cytotoxic effector molecules and cytokines in inflammatory myopathies. Bas Appl Myol 8:389-397
Goodman MN (1991) Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 260(5 pt 1):E727-730
Gordon JR, Galli SJ (1991) Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 174:103-107[Abstract]
Grounds MD (1999) Muscle regeneration: molecular aspects and therapeutic implications. Curr Opin Neurol 12:535-543[Medline]
Grounds MD, Davies MJ (1996) Chemotaxis in myogenesis. Bas Appl Myol 6:469-483
Han Y, Tuan T, Wu H, Hughes M, Garner WL (2000) TNF- stimulates activation of pro-MMP2 in human skin through NF-
B mediated induction of MT1-MMP. J Cell Sci 114:131-139
Heckmann M, AdelmannGrill BC, Hein R, Krieg T (1993) Biphasic effects of interleukin-1 alpha on dermal fibroblasts: enhancement of chemotactic responsiveness at low concentrations and of mRNA expression for collagenase at high concentrations. J Invest Dermatol 100:780-784[Abstract]
Heng JIT (1996) Expression of tumor necrosis factor-alpha in choline deficient, ethionine supplemented diet-induced preneoplastic liver. Department of Biochemistry. Perth, University of Western Australia
HodgeDufour J, Marino MW, Horton MR, Jungbluth A, Burdick RD, Strieter RM, Noble PW, Hunter CA, Pure E (1998) Inhibition of interferon gamma induced interleukin 12 productiona potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci USA 95:13806-13811
Hunt JS, Chen H, Hu X, Chen T, Morrison DC (1992) Tumour necrosis factor- gene expression in the tissues of normal mice. Cytokine 4:340-346[Medline]
Illei GG, Lipsky PE (2000) Novel, antigen-specific therapeutic approaches to autoimmune/inflammatory diseases. Curr Opin Immunol 12:712-718[Medline]
Ji SQ, Neustrom S, Willis GM, Spurlock ME (1998) Proinflammatory cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabolism or stress protein expression. J Interferon Cytokine Res 18:879-888[Medline]
Knight B, Yeoh GCT, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, Fausto N (2000) Impaired preneoplastic changes and liver tumor formation in TNF receptor type I knockout mice. J Exp Med 192:1809-1818
Korner H, Sedgwick JD (1996) Tumour necrosis factor and lymphotoxin: Molecular aspects and role in tissue-specific autoimmunity. Immunol Cell Biol 74:465-472[Medline]
Ksontini R, MacKay SLD, Moldawer LL (1998) Revisiting the role of tumour necrosis factor and the response to surgical injury and inflammation. Arch Surg 133:558-567
Kurek JB, Bower JJ, White JD, Muldoon CM, Austin LM (1998) Leukaemia inhibitory factor and other cytokines as factors influencing regeneration of skeletal muscle. Bas Appl Myol 8:347-360
Kurek JB, Nouri S, Kannourakis G, Murphy M, Austin L (1996) Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating muscle. Muscle Nerve 19:1291-1301[Medline]
LawsonSmith MJ, McGeachie JK (1997) Experimental skeletal muscle grafts as a model of regeneration. Aust NZ J Surg 67:35-39[Medline]
Lundberg IE, Nyberg PP (1998) New developments in the role of cytokines and chemokines in inflammatory myopathies. Curr Opin Rhematol 10:521-529[Medline]
Maier A (1997) Development and regeneration of muscle spindles in mammals and birds. Int J Dev Biol 41:1-17[Medline]
Maier A, Mayne R (1995) Basal lamina development in chicken muscle spindles. Dev Dyn 202:284-293[Medline]
Malaviya R, Ikeda T, Ross E, Abraham SN (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77-80[Medline]
Maley MA, Fan Y, Beilharz MW, Grounds MD (1994) Intrinsic differences in MyoD and myogenin expression between primary cultures of SJL/J and BALB/c skeletal muscle. Exp Cell Res 211:99-107[Medline]
Maley MAL, Davies MJ, Grounds MD (1995) Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp Cell Res 219:169-179[Medline]
Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B (1997) Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94:8093-8098
Matsuura K, Otsuka F, Fujisawa H (1998) Effects of interferons on tumour necrosis factor alpha production from human keratinocytes. Cytokine 10:500-505[Medline]
McGeachie JK, Allbrook D (1978) Cell proliferation in skeletal muscle following denervation or tenotomy. Cell Tissue Res 193:259-267[Medline]
McGeachie JK, Grounds MD (1987) Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. An autoradiographic study. Cell Tissue Res 248:125-130[Medline]
McGeachie JK, Grounds MD (1989) The onset of myogenesis in denervated mouse skeletal muscle regenerating after injury. Neuroscience 28:509-514[Medline]
McGeachie JK, Grounds MD, Partridge TA, Morgan JE (1993) Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J Neurol Sci 119:169-179[Medline]
McLennan IS, Poussart Y, Koishi K (2000) Development of skeletal muscles in transforming growth factor-beta 1 (TGF-beta 1) null-mutant mice. Dev Dyn 217:250-256[Medline]
Mitchell CA, McGeachie JK, Grounds MD (1992) Cellular differences in the regeneration of murine skeletal muscle: a quantitative histological study in SJL/J and BALB/c mice. Cell Tissue Res 269:159-166[Medline]
Murakami N, McLennan IS, Nonaka I, Koishi K, Baker C, HammondTooke G (1999) Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle Nerve 22:889-898[Medline]
Nahirney PC, Dow PR, Ovalle WK (1997) Quantitative morphology of mast cells in skeletal muscle of normal and genetically dystrophic mice. Anat Rec 247:341-349[Medline]
Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF (1998) Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci 18:2239-2246
Noguchi M, Hiwatashi N, Liu Z, Toyota T (1998) Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut 43:203-209
Prochazka A, Gorassini M (1998) Models of ensemble firing of muscle spindle afferents recorded during normal locomotion in cats. J Physiol 507(pt 1):277-291
Roberts P, McGeachie JK (1990) Endothelial cell activation during angiogenesis in freely transplanted skeletal muscles in mice and its relationship to the onset of myogenesis. J Anat 169:197-207[Medline]
Roberts P, McGeachie JK, Grounds MD (1997) The host environment determines strain-specific differences in the timing of skeletal muscle regeneration: cross-transplantation studies between SJL/J and BALB/c mice. J Anat 191:585-594[Medline]
Rodger J, Ziman M, Papadimitriou JM, Kay PH (1999) Pax7 is expressed in the capsules surrounding adult mouse neuromuscular spindles. Biochem Cell Biol 77:153-156[Medline]
Schindler R, Dinarello CA (1990) Interleukin 1. In Habenicht A, ed. Growth Factors, Differentiation Factors, and Cytokines. Berlin, Springer-Verlag, 85-102
SchmauderChock EA, Chock SP, Patchen ML (1994) Ultrastructural localization of tumour necrosis factor-alpha. Histochem J 26:142-151[Medline]
Sharief MK, Hentges R (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325:467-472[Abstract]
Shintani F, Nakaki T, Kanba S, Kato R, Asai M (1995) Role of interleukin-1 in stress responses. A putative neurotransmitter. Mol Neurobiol 10:47-71[Medline]
Spencer MJ, Marino MW, Winckler WM (2000) Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice. Neuromusc Disord 10:612-619[Medline]
Spencer MJ, Walsh CM, Dorshkind KA, Rodriguez EM, Tidball JG (1997) Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J Clin Invest 99:2745-2751
Storkus WJ, Tahara H, Lotze MT (1998) Interleukin-12. In Thomson AW, ed. The Cytokine Handbook. San Diego, Academic Press, 391-426
Szalay K, Duda E (1997) TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. Eur J Cell Biol 74:391-398[Medline]
Tateyama M, Nagano I, Yoshioka M, Chida K, Nakamura S, Itoyama Y (1997) Expression of tumor necrosis factor-alpha in muscles of polymyositis. J Neurol Sci 146:45-51[Medline]
Tews DS, Goebel HH (1996) Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol 55:342-347[Medline]
Tidball JG (1995) Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc 27:1022-1032[Medline]
Tracey KJ (1994) Tumour necrosis factor-alpha. In Thompson AW, ed. The Cytokine Handbook. San Diego, Academic Press, 289-304
Tracey KJ, Cerami A (1990) The biology of cachectin/tumor necrosis factor. In Habenicht A, ed. Growth Factors, Differentiation Factors, and Cytokines. Berlin, Springer-Verlag, 356-365
Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Yano M, Monden M (1998) Muscle wasting and IL-6. Bas Appl Myol 8:361-370
Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452[Medline]
Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316
Vilcek J, Palombella VJ, HenriksenDeStefano D, Swenson C, Feinman R, Hirai M, Tsujimoto M (1986) Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 163:632-643[Abstract]
von Boehmer H (1997) Lymphotoxins: from cytotoxicity to lymphoid organogenesis. Proc Natl Acad Sci USA 94:8926-8927
Ware CF, VanArsdale S, VanArsdale TL (1996) Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem 60:47-55[Medline]
Wedemeyer J, Tsai M, Galli SJ (2000) Role of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 12:624-631[Medline]
Wernig A, Irintchev A (1995) "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells. J Neurol Sci 130:190-196[Medline]
White JD, Scaffidi A, Davies M, McGeachie J, Grounds MD (2000) Myotube formation is delayed but not prevented in MyoD-deficient skeletal muscle: studies in regenerating whole muscle grafts of adult mice. J Histochem Cytochem 48:1531-1544
Wysocki AB, Kusakabe AO, Chang S, Tuan TL (1999) Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair Regen 7:154-165[Medline]
Yamada Y, Kirillova I, Peschon JJ, Fausto N (1997) Initiation of liver growth by tumour necrosis factor: deficient liver regeneration in mice lacking type I tumour necrosis factor receptor. Proc Natl Acad Sci USA 94:1441-1446
Zamir O, Hasselgren P, Kunkel SL, Frederick J, Higashiguchi T, Fischer JE (1992) Evidence that tumour necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 127:170-174[Abstract]